Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: Autoimmune Neurologists, General Neurologists, Neuromuscular Specialists, Rheumatologists, Medical Geneticists, Neuro-oncologists, Medical Oncologists, Epileptologists, Infectious Disease Specialists
+ Sample video: contact me for sample video
+ Information:
The 2026 American Academy of Neurology (AAN) Autoimmune Neurology Conference is a specialized medical event scheduled for August 7–8, 2026, in Houston, Texas, with online accessibility. This conference provides a comprehensive platform for the neurology community to explore the latest advances, diagnostic criteria, and treatment strategies in the rapidly evolving field of autoimmune neurology. It is designed to bring together leading neurologists, researchers, and early-career specialists to share emerging basic science evidence, practice-shaping clinical data, and groundbreaking therapeutic platforms.
Learning Objectives
Upon completion of this conference, participants should be able to:
-
Discuss new knowledge and emerging basic science evidence to assist with the recognition, diagnosis, and treatment planning for various autoimmune neurological disorders.
-
Implement the latest diagnostic criteria and treatment strategies into clinical practice for complex neuroinflammatory presentations.
-
Evaluate interactive case studies and expert-led debates on controversial topics in autoimmune neurology to improve patient-centered care.
-
Identify the pathophysiology, genetic factors, and targeted therapies for specific conditions such as Myasthenia Gravis, Encephalitis, NMOSD, and cancer-associated autoimmunity.
-
Analyze the role of emerging diagnostics and novel therapeutics, including CAR-T cell therapies, in the management of severe autoimmune neurology disorders.
Target Audience
- This program is intended for MD/DOs, NPs, PAs, RNs, neurologists, researchers, early-career specialists, fellows, residents, and all members of the healthcare team interested in the study and treatment of autoimmune neurological diseases.
- Best for Autoimmune Neurologists, General Neurologists, Neuromuscular Specialists, Rheumatologists, Medical Geneticists, Neuro-oncologists, Medical Oncologists, Epileptologists, Infectious Disease Specialists, Neuro-ophthalmologists, Neuroimmunologists, Movement Disorder Specialists, Pulmonologists, and Hematologist-Oncologists.
+ Topics:
- C1 | Autoimmune Neurology Updates
Section: 10 Presentations 1 Document - C2 | Myasthenia Gravis: Pathophysiology to Effective Treatments
Section: 6 Presentations - C3 | Keynote: The Glymphatic System
Section: 2 Presentations - C4 | Neuro-rheumatology
Section: 10 Presentations - C5 | Inflammatory Myopathies and Autoimmune Neuromuscular Junction Disorders
Section: 12 Presentations - C6 | Genetics and Neurological Autoimmunity
Section: 10 Presentations - C7 | Keynote: Paraneoplastic Neurological Syndromes
Section: 2 Presentations - C8 | Case Studies
Section: 12 Presentations - C9 | Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disease (NMOSD)
Section: 10 Presentations - C10 | Demyelinating Neuropathies
Section: 12 Presentations - C11 | Autoimmune and Infectious Encephalitis and Acute Seizures
Section: 10 Presentations - C12 | MOG-antibody Associated Disease
Section: 10 Presentations - C13 | Other Inflammatory Neuropathies
Section: 10 Presentations - C14 | Autoimmune Encephalitis: Pathophysiology to Treatment
Section: 10 Presentations - C15 | Clinical Approach to Suspected Myelopathy
Section: 10 Presentations - C16 | Autoimmune Movement Disorders
Section: 10 Presentations - C17 | Cancer-associated Neurological Autoimmunity
Section: 10 Presentations - C18 | Neurosarcoidosis
Section: 10 Presentations - C19 | Focus on Emerging Diagnostics
Section: 10 Presentations 1 Document - C20 | CAR-T Cell Therapies and Neurology
Section: 10 Presentations 3 Documents - C21 | Closing Debates
Section: 14 Presentations 6 Documents
Reviews
There are no reviews yet.